Rapid and Sustained Influence of Intravenous Zoledronic Acid on Course of Pain and Analgesics Consumption in Patients with Cancer with Bone Metastases: A Multicenter Open-Label Study Over 1 Year

Albrecht Kretzschmar(Roche (Switzerland)), Gerhard Ehninger(University Hospital Carl Gustav Carus), Thomas Wiege(Franklin University), H.F. Hinrichs, Salah‐Eddin Al‐Batran(Goethe University Frankfurt), Ulrike Haus(Novartis (France)), Katja Schmidt(Novartis (France)), Alexandra Kirner(Novartis (France)), Hans Jochen Illiger(Klinikum Oldenburg), Manfred Kindler(Praxis), Thomas Steck(Klinikum Passau), Volker Heinemann(LMU Klinikum)
Supportive Cancer Therapy
September 1, 2007
10.3816/sct.2007.n.016
Cited by 19

Related Papers

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
|The Lancet|2019|2.6k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
|The Lancet Oncology|2014|1.7k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie
|Journal of Clinical Oncology|2008|784